Immunohistochemistry CD79a Test: Comprehensive B-Cell Marker Analysis
Understanding the Immunohistochemistry CD79a Test
The Immunohistochemistry CD79a Test represents a cornerstone in modern cancer diagnostics, specifically designed to detect the presence of CD79a protein markers in tissue samples. This sophisticated laboratory technique utilizes specific antibodies that bind to CD79a antigens, providing visual evidence of B-cell lineage through microscopic examination. As a critical component of the B-cell receptor complex, CD79a serves as a reliable indicator of B-cell development and function, making this test invaluable for hematopathologists and oncologists in their diagnostic workflow.
Scientific Foundation and Clinical Significance
CD79a is a transmembrane protein that forms part of the B-cell receptor complex, playing an essential role in B-cell development, activation, and signaling. The Immunohistochemistry CD79a Test employs highly specific monoclonal antibodies that target this protein, creating a visible reaction when CD79a-positive cells are present. This test has revolutionized the classification of lymphoid malignancies by enabling precise identification of B-cell origin, which directly influences treatment selection and prognostic assessment.
What the CD79a Test Detects and Measures
The Immunohistochemistry CD79a Test specifically identifies and quantifies the presence of CD79a protein expression in tissue specimens. This advanced diagnostic tool provides critical information about:
- B-cell lineage confirmation in lymphoid malignancies
- Differentiation between B-cell and T-cell lymphomas
- Identification of precursor B-cell acute lymphoblastic leukemia
- Detection of mature B-cell neoplasms including diffuse large B-cell lymphoma
- Assessment of B-cell development and maturation stages
Who Should Consider the CD79a Test?
This specialized diagnostic test is recommended for patients presenting with clinical indications that suggest potential B-cell disorders:
- Patients with unexplained lymph node enlargement or swelling
- Individuals with abnormal complete blood count results suggesting lymphoid malignancy
- Patients with suspected lymphoma based on imaging studies
- Cases requiring differentiation between Hodgkin and non-Hodgkin lymphoma
- Patients with bone marrow involvement of unknown origin
- Individuals with symptoms including night sweats, unexplained weight loss, or persistent fever
Key Benefits of CD79a Testing
Choosing the Immunohistochemistry CD79a Test provides numerous advantages for accurate diagnosis and treatment planning:
- Precise Diagnosis: Enables accurate classification of lymphoid malignancies
- Treatment Guidance: Helps oncologists select appropriate targeted therapies
- Prognostic Value: Provides important information about disease behavior and expected outcomes
- Minimally Invasive: Utilizes existing tissue samples from biopsies
- Rapid Results: Typically available within 5-7 days for timely treatment decisions
- Cost-Effective: Priced at only $88 USD with comprehensive diagnostic value
Understanding Your Test Results
Interpreting CD79a test results requires specialized expertise from pathologists and oncologists. Generally, results fall into these categories:
- Positive Result: Indicates the presence of CD79a protein, confirming B-cell lineage in the tested tissue
- Negative Result: Suggests absence of CD79a, which may indicate T-cell origin or other cell types
- Focal Positivity: Limited CD79a expression that may require additional testing
- Variable Intensity: Different levels of staining that provide information about cell maturity and differentiation
Your healthcare provider will interpret these results in the context of your complete clinical picture, including other laboratory findings, imaging studies, and physical examination results.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry CD79a Test | $88 USD | $126 USD |
Turnaround Time and Sample Requirements
We accept samples daily until 6:00 PM with the following processing timelines:
- Block Samples: 5 days
- Tissue Biopsy: 5 days
- Tissue Large Complex: 7 days
Sample Type: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature.
Required Documentation: Please provide a copy of the Histopathology report, Site of biopsy, and Clinical history.
Nationwide Availability
General Genetics Corporation provides comprehensive diagnostic services across the United States, with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.
Book Your Test Today
Take the first step toward accurate diagnosis and effective treatment planning. Our experienced team is ready to assist you with scheduling and answer any questions about the Immunohistochemistry CD79a Test.
Call or WhatsApp: +1(267) 388-9828
Schedule your appointment today and benefit from our specialized expertise in cancer diagnostics. Early and accurate detection can make a significant difference in your treatment journey.
